Edinburgh trial of screening for breast cancer: mortality at seven years
- PMID: 1967717
- DOI: 10.1016/0140-6736(90)90066-e
Edinburgh trial of screening for breast cancer: mortality at seven years
Abstract
Between 1979 and 1981, 45,130 women in Edinburgh aged 45-64 were entered into a randomised trial of breast cancer screening by mammography and clinical examination. The initial attendance rate was 61% but this varied according to age and socioeconomic status and decreased over succeeding years. The cancer detection rate was 6.2 per 1000 women attending at the first visit; the rate fell to around 3 per 1000 in the years when mammography was routinely repeated and to around 1 per 1000 at the intervening visits with clinical examination alone as the screening method. After 7 years of follow-up the mortality reduction achieved was 17% (relative risk = 0.83, 95% CI 0.58-1.18), which was not statistically significant, even when corrected for socioeconomic status. In women aged 50 years and over a mortality reduction of 20% was achieved.
Comment in
-
Edinburgh trial of screening for breast cancer.Lancet. 1990 Apr 21;335(8695):968-9. Lancet. 1990. PMID: 1970035 No abstract available.
-
Edinburgh trial of screening for breast cancer.Lancet. 1990 May 26;335(8700):1290-1. doi: 10.1016/0140-6736(90)91367-j. Lancet. 1990. PMID: 1971369 No abstract available.
Similar articles
-
Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.CMAJ. 1992 Nov 15;147(10):1459-76. CMAJ. 1992. PMID: 1423087 Free PMC article. Clinical Trial.
-
Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.CMAJ. 1992 Nov 15;147(10):1477-88. CMAJ. 1992. PMID: 1423088 Free PMC article. Clinical Trial.
-
14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening.Lancet. 1999 Jun 5;353(9168):1903-8. doi: 10.1016/s0140-6736(98)07413-3. Lancet. 1999. PMID: 10371567 Clinical Trial.
-
Mammographic screening of women aged 40 to 49 years. Is it justified?Obstet Gynecol Clin North Am. 1994 Dec;21(4):587-606. Obstet Gynecol Clin North Am. 1994. PMID: 7731636 Review.
-
Current management of primary breast cancer. Part I: Screening, diagnosis, staging and local treatment of stage I and II disease.Mo Med. 1990 Sep;87(9):684-90. Mo Med. 1990. PMID: 2215472 Review.
Cited by
-
Further evidence of benefits of a (non-randomised) breast cancer screening programme: the DOM project.J Epidemiol Community Health. 1992 Aug;46(4):382-6. doi: 10.1136/jech.46.4.382. J Epidemiol Community Health. 1992. PMID: 1431712 Free PMC article.
-
The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up.Br J Cancer. 1994 Sep;70(3):542-8. doi: 10.1038/bjc.1994.342. Br J Cancer. 1994. PMID: 8080744 Free PMC article. Clinical Trial.
-
The impact of reminder letters on attendance for breast cancer screening.Ir J Med Sci. 1999 Jan-Mar;168(1):29-32. doi: 10.1007/BF02939577. Ir J Med Sci. 1999. PMID: 10098340 Clinical Trial.
-
The influence of breast self-examination on subsequent mammography participation.Am J Public Health. 2005 Mar;95(3):506-11. doi: 10.2105/AJPH.2003.032656. Am J Public Health. 2005. PMID: 15727985 Free PMC article.
-
Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.CMAJ. 1992 Nov 15;147(10):1459-76. CMAJ. 1992. PMID: 1423087 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical